-
341
The role of Box A of HMGB1 in producing γH2AX associated DNA breaks in lung cancer
Published 2025-01-01Subjects: “…Lung cancer…”
Get full text
Article -
342
Multiparameter body composition analysis on chest CT predicts clinical outcomes in resectable non-small cell lung cancer
Published 2025-02-01Subjects: “…Lung cancer…”
Get full text
Article -
343
Hydrodissection technique for pain relief during peri-microwave ablation in patients with subpleural non-small cell lung cancers
Published 2024-12-01“…Purpose This study aimed to assess the application value of the hydrodissection technique (HT) for pain relief during peri-microwave ablation (MWA) in patients with subpleural non-small cell lung cancers (NSCLCs).Methods This retrospective study comprised 218 patients with subpleural NSCLCs who underwent computed tomography (CT)-guided percutaneous MWA. …”
Get full text
Article -
344
Association of polymorphism <i>TP53</i> Arg72Pro with radon-induced lung cancer in the Kazakh population
Published 2019-08-01Subjects: Get full text
Article -
345
The utility of artificial intelligence in identifying radiological evidence of lung cancer and pulmonary tuberculosis in a high-burden tuberculosis setting
Published 2024-05-01Subjects: “…Utility, artificial intelligence, pulmonary tuberculosis, lung cancer, computer aided detection.…”
Get full text
Article -
346
-
347
Recent trends and therapeutic potential of phytoceutical‐based nanoparticle delivery systems in mitigating non‐small cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
348
Careful take-off by the EQ-5D-5L tool in lung cancer: fly little one, fly!
Published 2024-07-01Get full text
Article -
349
A Case of Long-Term Survival after Checkpoint Inhibitor Pneumonitis in a Patient with Squamous Cell Lung Cancer
Published 2019-01-01“…We herein report the case of a woman with squamous cell lung cancer who was a long-term survivor after CIP. …”
Get full text
Article -
350
Radiotherapy Combined with Immunotherapy and Chemotherapy Improves Prognosis and Demonstrates Synergistic Effects in Extensive-stage Small Cell Lung Cancer
Published 2024-11-01“…Chinese Journal of Lung Cancer…”
Get full text
Article -
351
Standardized Mortality Ratios (SMRs) and Radon Exposure Analysis for Lung Cancer and All-Cause Mortality in Locorotondo, Southern Italy
Published 2024-12-01Subjects: Get full text
Article -
352
C/EBPβ Regulates HIF-1α-Driven Invasion of Non-Small-Cell Lung Cancer Cells
Published 2024-12-01Subjects: Get full text
Article -
353
Preoperative immunochemotherapy versus chemotherapy as first-line treatment for patients with stage I–IIIB small-cell lung cancer
Published 2025-01-01Subjects: Get full text
Article -
354
Lesser Toxicities of Belotecan in Patients with Small Cell Lung Cancer: A Retrospective Single-Center Study of Camptothecin Analogs
Published 2016-01-01“…Topotecan and belotecan are camptothecin derivatives that are used to treat small cell lung cancer (SCLC). This study compared the toxicities and efficacies of belotecan and topotecan monotherapies in patients with SCLC. …”
Get full text
Article -
355
A benchmark of deep learning approaches to predict lung cancer risk using national lung screening trial cohort
Published 2025-01-01“…Abstract Deep learning (DL) methods have demonstrated remarkable effectiveness in assisting with lung cancer risk prediction tasks using computed tomography (CT) scans. …”
Get full text
Article -
356
Long term efficacy and safety of Lorlatinib in ALK-positive non-small cell lung cancer: A case report
Published 2025-03-01Subjects: Get full text
Article -
357
FGF23-related hypophosphatemia in a patient with small cell lung cancer: a case report and literature review
Published 2023-10-01Subjects: Get full text
Article -
358
Efficacy of preoperative pulmonary rehabilitation in lung cancer patients: a systematic review and meta-analysis of randomized controlled trials
Published 2025-01-01Subjects: “…Lung cancer…”
Get full text
Article -
359
Putting COPD and Lung Cancer Guidelines Into Practice: A Canadian Thoracic Society and American College of Chest Physicians Perspective
Published 2004-01-01“…Update your knowledge on lung cancer as presented by contributors to the 2003 ACCP Evidence-Based Guidelines on Lung Cancer. …”
Get full text
Article -
360
Utilizing TP53 hotspot mutations as effective predictors of gemcitabine treatment outcome in non-small-cell lung cancer
Published 2025-01-01“…Abstract TP53 mutations are recognized to correlate with a worse prognosis in individuals with non-small cell lung cancer (NSCLC). There exists an immediate necessity to pinpoint selective treatment for patients carrying TP53 mutations. …”
Get full text
Article